Participated · Series A · Sep 2018

Founded in 2015 and based in San Francisco, CA and Cambridge, MA, Cricket Health delivers value-based care for patients with chronic kidney disease and ESKD. Its StageSmart™ predictive analytics model identifies patients in stage 3b and beyond with 96 percent accuracy, enabling risk stratification for plans and providers. The company provides stage-specific care through MyCricket™, a comprehensive patient support service that includes a multidisciplinary care team, peer support, and virtual, telephone, or in-person resources. Cricket Health reports that its evidence-based approach increases transplant referrals, raises utilization of home dialysis, and reduces unnecessary hospitalizations for patients who progress to ESKD. The company intends to use the new funding for rapid expansion to meet demand for its care model across the United States. With the Series B, Cricket has raised more than $120 million in equity and debt financing to date. Cricket Health provides personalized, evidence-based care for chronic kidney disease (CKD) and end-stage renal disease (ESRD) through a multidisciplinary care team. The company partners with payers and providers to identify at-risk patients, intervene early to slow disease progression, and educate patients about treatment options. If patients progress to ESRD, Cricket supports transplant, home dialysis, conservative care, or in-center dialysis. Cricket has signed payer deals in California with Blue Shield of California and Cigna and says it serves patients in current markets including California and Texas, with plans to expand to other states. In October 2020 the company received $15 million in debt financing from K2 HealthVentures to support growth, add payer customers, and support more nephrology practices. Founded in 2015 and based in San Francisco and Cambridge, Cricket's leadership includes experts in nephrology, health care, and technology. Cricket Health provides tech-enabled integrated nephrology and dialysis care to CKD and ESRD patients, working with risk-bearing payers and health systems to identify high-risk patients before kidney failure. Founded in 2015 and based in San Francisco, the company focuses on preserving kidney function and delaying progression to dialysis. Its care model combines a nephrology practice (remote, in-person, and at-home care), a multidisciplinary care team, patient education and 24/7 peer and clinical support technology, and dialysis delivered at home or in redesigned centers. Treatment priorities include slowing kidney-failure progression, keeping patients out of the hospital, ensuring prepared transitions, and supporting patients on any ESRD treatment path. Cricket plans to use new funding to expand tech-enabled programs and its clinical presence, further develop care management for ESRD patients to delay dialysis, and create new home dialysis and in-center programs. Recent leadership additions include Chief Medical Officer Carmen A. Peralta, MD, MAS, and Chief Business Officer Danny Shapiro; medical advisors include Glenn Chertow, Michael Shlipak, and Joel Glickman. Cricket Health provides scalable solutions for patients managing advanced-stage CKD and ESRD, including patient education and clinical support. Its first product, Health Options Patient Education (HOPE), connects advanced-stage CKD patients to content, clinical expertise and a network of healthcare professionals, peers and mentors. The company is also developing machine-learning algorithms to identify persons with CKD within hospitals' electronic health record data. In addition, Cricket is building knowledge-rich decision-support systems to improve CKD management across the patient journey. Leadership includes co-founder and CEO Arvind Rajan and co-founder Vince Kim. The company completed a $2.5M seed funding round reported in October 2016.

Led · Equity · Aug 2018

MDLIVE operates a virtual primary care digital health platform that connects patients with a network of board-certified physicians, dermatologists, psychiatrists and therapists specially trained in virtual care. The company leverages technology and artificial intelligence to simplify and streamline care, often connecting providers and patients within minutes. MDLIVE serves more than 45 million members nationwide. It is focused on ongoing strategic expansion of its virtual primary care platform and the launch of supporting products and services. To support growth, MDLIVE recently completed new equity and debt financings. The company is led by chairman and CEO Charles Jones. Mdlive operates a HIPAA-compliant, cloud-based telehealth service platform that provides 24/7/365 virtual access to U.S. board-certified doctors, counselors, psychiatrists and dermatologists. The company partners with health systems, health plans and hospitals to offer virtual visits and registered users can receive consultations from home or on the go. Mdlive serves more than 27 million Americans through its platform. Founded in 2009 and based in Sunrise, Fla., the company focuses on expanding virtual access across multiple specialties. Mdlive intends to use recent financing to continue growing its reach. MDLIVE provides virtual consultations with U.S. board-certified physicians and licensed therapists through a HIPAA-compliant cloud-based platform. The system enables payers and providers to collect and share clinical data from patient medical records, lab results and in-home biometric devices for real-time risk assessments, wellness advice, diagnosis and treatment. MDLIVE partners with established industry players, including Walgreens, Microsoft and major health systems across the country. The company plans to use recent funding to continue organic growth and to expand its acquisition strategy and consumer reach. MDLIVE was founded in 2009 and is led by president and CEO Randy Parker. The company positions itself as one of the most comprehensive virtual health networks in the United States. MDLIVE provides telehealth, online and on-demand healthcare via a cloud-based Virtual Medical Office platform that connects patients, providers and plan administrators through voice, video, email and mobile devices. The company works with board-certified physicians and therapists nationwide to deliver 24/7/365 care, including diagnosis and non-controlled prescriptions for routine conditions. Its platform is HIPAA- and PHI-compliant and is used by consumers, employers, payers, hospitals, physician groups and accountable care organizations. MDLIVE positions itself as the nation’s largest telehealth network and emphasizes a customer-centric approach and decision-support tools for consumers. The company said it will use the new funding to further build out its healthcare system in the cloud and to integrate a Second Opinion program for patients. MDLIVE was founded in 2006 and is headquartered in Sunrise, Florida.